Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

P. Jain; J. Gutierrez Bugarin; A. Guha; C. Jain; N. Patil; T. Shen; I. Stanevich; V. Nikore; K. Margolin; M. Ernstoff; V. Velcheti; J. Barnholtz-Sloan; A. Dowlati

doi:10.1016/j.esmoop.2021.100286

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

P. Jain
, J. Gutierrez Bugarin
, A. Guha
, C. Jain
, N. Patil
, T. Shen
, I. Stanevich
, V. Nikore
, K. Margolin
, M. Ernstoff
, V. Velcheti
, J. Barnholtz-Sloan
, A. Dowlati

Cardiology

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	Undefined
Journal	ESMO Open
DOIs	https://doi.org/10.1016/j.esmoop.2021.100286
State	Published - Dec 2021

Access to Document

10.1016/j.esmoop.2021.100286

Cite this

Jain, P., Bugarin, J. G., Guha, A., Jain, C., Patil, N., Shen, T., Stanevich, I., Nikore, V., Margolin, K., Ernstoff, M., Velcheti, V., Barnholtz-Sloan, J., & Dowlati, A. (2021). Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’. ESMO Open. https://doi.org/10.1016/j.esmoop.2021.100286

Jain, P, Bugarin, JG, Guha, A, Jain, C, Patil, N, Shen, T, Stanevich, I, Nikore, V, Margolin, K, Ernstoff, M, Velcheti, V, Barnholtz-Sloan, J & Dowlati, A 2021, 'Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’', ESMO Open. https://doi.org/10.1016/j.esmoop.2021.100286

@article{c693d9347b954984ad184a2f76e26242,

title = "Corrigendum to {\textquoteleft}Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States{\textquoteright}",

author = "P. Jain and Bugarin, \{J. Gutierrez\} and A. Guha and C. Jain and N. Patil and T. Shen and I. Stanevich and V. Nikore and K. Margolin and M. Ernstoff and V. Velcheti and J. Barnholtz-Sloan and A. Dowlati",

year = "2021",

month = dec,

doi = "10.1016/j.esmoop.2021.100286",

language = "Undefined",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

AU - Jain, P.

AU - Bugarin, J. Gutierrez

AU - Guha, A.

AU - Jain, C.

AU - Patil, N.

AU - Shen, T.

AU - Stanevich, I.

AU - Nikore, V.

AU - Margolin, K.

AU - Ernstoff, M.

AU - Velcheti, V.

AU - Barnholtz-Sloan, J.

AU - Dowlati, A.

PY - 2021/12

Y1 - 2021/12

UR - https://doi.org/10.1016/j.esmoop.2021.100286

U2 - 10.1016/j.esmoop.2021.100286

DO - 10.1016/j.esmoop.2021.100286

M3 - Article

C2 - 34678570

SN - 2059-7029

JO - ESMO Open

JF - ESMO Open

ER -

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

Access to Document

Other files and links

Cite this